Does 18-fluorodeoxyglucose (FDG) uptake by positron emission tomography/computed tomography (PET/CT) predict survival in advanced pancreatic cancer? A single-institution experience. This is an ASCO ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight, creator of the TFLN Chipletâ„¢ platform, today announced the launch of its groundbreaking 110 GHz Low VÏ€ Intensity Modulator, featuring industry-standard ...
For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback